These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 19253491)

  • 41. The greatest happiness of the greatest number? Policy actors' perspectives on the limits of economic evaluation as a tool for informing health care coverage decisions in Thailand.
    Teerawattananon Y; Russell S
    BMC Health Serv Res; 2008 Sep; 8():197. PubMed ID: 18817579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. End-user involvement in health technology assessment (HTA) development: a way to increase impact.
    McGregor M; Brophy JM
    Int J Technol Assess Health Care; 2005; 21(2):263-7. PubMed ID: 15921068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evidence-based medical approach to clinical medicine and health policy-making in the 21st century].
    Li YP; Tao TJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):548-9. PubMed ID: 12905676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health technology assessment in Poland and Scotland: comparison of process and decisions.
    Kolasa K; Wasiak R
    Int J Technol Assess Health Care; 2012 Jan; 28(1):70-6. PubMed ID: 22617739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence-based medicine beyond the bedside: keeping an eye on context.
    Tilburt JC
    J Eval Clin Pract; 2008 Oct; 14(5):721-5. PubMed ID: 19018902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Defining products for a new health technology assessment agency in Madrid, Spain: a survey of decision makers.
    Andradas E; Blasco JA; Valentín B; López-Pedraza MJ; Gracia FJ
    Int J Technol Assess Health Care; 2008; 24(1):60-9. PubMed ID: 18218170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spanish recommendations on economic evaluation of health technologies.
    López-Bastida J; Oliva J; Antoñanzas F; García-Altés A; Gisbert R; Mar J; Puig-Junoy J
    Eur J Health Econ; 2010 Oct; 11(5):513-20. PubMed ID: 20405159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Technology assessment and coverage decision making.
    McGivney WT
    AAPPO J; 1994; 4(5):11-2, 14-7. PubMed ID: 10150666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reforming the health sector in Thailand: the role of policy actors on the policy stage.
    Green A
    Int J Health Plann Manage; 2000; 15(1):39-59. PubMed ID: 10947567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Policy roadmap for stem cell technology in Thailand.
    Kiatpongsan S
    J Med Assoc Thai; 2008 Jan; 91(1):124-8. PubMed ID: 18386556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Linking evidence from health technology assessments to policy and decision making: the Alberta model.
    Borowski HZ; Brehaut J; Hailey D
    Int J Technol Assess Health Care; 2007; 23(2):155-61. PubMed ID: 17493300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KNOW ESSENTIALS: a tool for informed decisions in the absence of formal HTA systems.
    Mathew JL
    Int J Technol Assess Health Care; 2011 Apr; 27(2):139-50. PubMed ID: 21447262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand?
    Tarride JE; McCarron CE; Lim M; Bowen JM; Blackhouse G; Hopkins R; O'Reilly D; Xie F; Goeree R
    Int J Technol Assess Health Care; 2008; 24(4):437-44. PubMed ID: 18828938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Health technology assessment in Denmark: strategy, implementation, and developments.
    Sigmund H; Kristensen FB
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():94-101. PubMed ID: 19505351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modelling in the economic evaluation of health care: selecting the appropriate approach.
    Barton P; Bryan S; Robinson S
    J Health Serv Res Policy; 2004 Apr; 9(2):110-8. PubMed ID: 15099459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are economic evaluations and health technology assessments increasingly demanded in times of rationing health services? The case of the Argentine financial crisis.
    Rubinstein A; Belizán M; Discacciati V
    Int J Technol Assess Health Care; 2007; 23(2):169-76. PubMed ID: 17493302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
    Lopert R
    Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health technology assessment in the United States.
    Luce B; Cohen RS
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():33-41. PubMed ID: 19505350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis.
    Eddy D
    Health Aff (Millwood); 2007; 26(4):w500-15. PubMed ID: 17580317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.